NCT00750451View on ClinicalTrials.gov

Low Molecular Weight Heparin in Recurrent Implantation Failure

NACompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
InfertilityFertilization in VitroRecurrent Implantation Failure
Interventions
DRUG

low molecular weight heparin (enoxaparine sodium)

1 mg/kg/day subcutaneously in the luteal phase after IVF treatment

DRUG

crinone 8% gel

routine luteal phase support with progesterone gel

Trial Locations (1)

34365

Assisted Reproduction Unit of the American Hospital of Istanbul, Istanbul

All Listed Sponsors
lead

V.K.V. American Hospital, Istanbul

OTHER

NCT00750451 - Low Molecular Weight Heparin in Recurrent Implantation Failure | Biotech Hunter | Biotech Hunter